Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease

INTRODUCTION: Recurrence of gastrointestinal stromal tumors (GISTs) after surgical resection and imatinib mesylate (IM) adjuvant therapy poses a significant treatment challenge. We present the case of a patient who underwent surgical resection after recurrence and review the current literature regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Platoff, Rebecca M., Morano, William F., Marconcini, Luiz, DeLeo, Nicholas, Mapow, Beth L., Styler, Michael, Bowne, Wilbur B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733166/
https://www.ncbi.nlm.nih.gov/pubmed/29333308
http://dx.doi.org/10.1155/2017/8349090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733166/
https://www.ncbi.nlm.nih.gov/pubmed/29333308
http://dx.doi.org/10.1155/2017/8349090

Ejemplares similares